Your browser doesn't support javascript.
loading
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Lipsyc-Sharf, Marla; Ou, Fang-Shu; Yurgelun, Matthew B; Rubinson, Douglas A; Schrag, Deborah; Dakhil, Shaker R; Stella, Philip J; Weckstein, Douglas J; Wender, Donald B; Faggen, Meredith; Zemla, Tyler J; Heying, Erica N; Schuetz, Samantha R; Noble, Stephanie; Meyerhardt, Jeffrey A; Bekaii-Saab, Tanios; Fuchs, Charles S; Ng, Kimmie.
Afiliação
  • Lipsyc-Sharf M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ou FS; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Schrag D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dakhil SR; Cancer Center of Kansas, Wichita, KS, USA.
  • Stella PJ; St. Joseph Mercy Hospital, Ypsilanti, MI, USA.
  • Weckstein DJ; New Hampshire Oncology Hematology, Hooksett, NH, USA.
  • Wender DB; June E. Nylen Cancer Center, Sioux City, IA, USA.
  • Faggen M; Dana-Farber at South Shore Hospital, South Weymouth, MA, USA.
  • Zemla TJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Heying EN; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Schuetz SR; University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Noble S; ACCRU, Mayo Clinic, Rochester, MN, USA.
  • Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bekaii-Saab T; Mayo Clinic Cancer Center, Phoenix, AZ, USA.
  • Fuchs CS; Yale Cancer Center, New Haven, CT, USA.
  • Ng K; Genentech, South San Francisco, CA, USA.
Oncologist ; 27(4): 292-298, 2022 04 05.
Article em En | MEDLINE | ID: mdl-35380713

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article